Bruce F Wesson - Net Worth and Insider Trading
Bruce F Wesson Net Worth
The estimated net worth of Bruce F Wesson is at least $827,862 dollars as of 2024-04-18. Bruce F Wesson is the Director of Derma Sciences Inc and owns about 94,963 shares of Derma Sciences Inc (DSCI) stock worth over $664,741. Bruce F Wesson is the Director of MedAssets Inc and owns about 5,168 shares of MedAssets Inc (MDAS) stock worth over $162,017. Bruce F Wesson is also the Director of Acura Pharmaceuticals Inc and owns about 394,404 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $1,104. Details can be seen in Bruce F Wesson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bruce F Wesson has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).
Transaction Summary of Bruce F Wesson
Bruce F Wesson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruce F Wesson owns 4 companies in total, including Acura Pharmaceuticals Inc (ACUR) , Derma Sciences Inc (DSCI) , and MedAssets Inc (MDAS) among others .
Click here to see the complete history of Bruce F Wesson’s form 4 insider trades.
Insider Ownership Summary of Bruce F Wesson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | director |
| DSCI | Derma Sciences Inc | 2016-05-31 | other: Former Director |
| MDAS | MedAssets Inc | 2016-01-27 | director |
| CHMT | Chemtura Corp | 2008-02-28 | director |
Bruce F Wesson Latest Holdings Summary
Bruce F Wesson currently owns a total of 3 stocks. Among these stocks, Bruce F Wesson owns 94,963 shares of Derma Sciences Inc (DSCI) as of August 13, 2015, with a value of $664,741 and a weighting of 80.3%. Bruce F Wesson owns 5,168 shares of MedAssets Inc (MDAS) as of November 21, 2013, with a value of $162,017 and a weighting of 19.57%. Bruce F Wesson also owns 394,404 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $1,104 and a weighting of 0.13%.
Latest Holdings of Bruce F Wesson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DSCI | Derma Sciences Inc | 2015-08-13 | 94,963 | 7.00 | 664,741 |
| MDAS | MedAssets Inc | 2013-11-21 | 5,168 | 31.35 | 162,017 |
| ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 394,404 | 0.00 | 1,104 |
Holding Weightings of Bruce F Wesson
Bruce F Wesson Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in Derma Sciences Inc (DSCI) over the past 5 years. The most-recent trade in Derma Sciences Inc is the acquisition of 10,000 shares on August 13, 2015, which cost Bruce F Wesson around $65,800.
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in MedAssets Inc (MDAS) over the past 5 years. The most-recent trade in MedAssets Inc is the sale of 60,263 shares on November 21, 2013, which brought Bruce F Wesson around $1 Million.
According to the SEC Form 4 filings, Bruce F Wesson has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 335,734 shares on December 14, 2017, which cost Bruce F Wesson around $33,573.
Insider Trading History of Bruce F Wesson
- 1
Bruce F Wesson Trading Performance
GuruFocus tracks the stock performance after each of Bruce F Wesson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce F Wesson is 18.96%. GuruFocus also compares Bruce F Wesson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce F Wesson within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruce F Wesson's insider trading performs compared to the benchmark.
Performance of Bruce F Wesson
Average Return
16.34%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.56 | 18.96 | 4.23 | 16.34 | 24.14 | 5.08 |
| Relative Return to S&P 500(%) | 8.17 | 10.26 | -3.12 | 2.71 | 4.7 | -13.25 |
Bruce F Wesson Ownership Network
Ownership Network List of Bruce F Wesson
Ownership Network Relation of Bruce F Wesson
Bruce F Wesson Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
Bruce F Wesson is the director of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and President & CEO Robert B Jones .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
Bruce F Wesson Mailing Address
Above is the net worth, insider trading, and ownership report for Bruce F Wesson. You might contact Bruce F Wesson via mailing address: 1827 Pacific St Brooklyn Ny 11233.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
